iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.415
+0.015 (1.07%)
Aug 3, 2026, 11:39 AM EDT - Market open
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $70.3 million as of August 3, 2026. Its market cap has increased by 557.67% in one year.
Market Cap
70.30M
Enterprise Value
-2.92M
1-Year Change
557.67%
Ranking
Category
Stock Price
$1.42
ChartMarket Cap Chart
Since August 19, 2008, iBio, Inc.'s market cap has increased from $14.01M to $70.30M, an increase of 401.66%. That is a compound annual growth rate of 9.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 70.30M | 61.97% |
| Dec 31, 2025 | 43.40M | 93.61% |
| Dec 31, 2024 | 22.42M | 716.05% |
| Dec 29, 2023 | 2.75M | -41.32% |
| Dec 30, 2022 | 4.68M | -96.09% |
| Dec 31, 2021 | 119.66M | -46.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 74.45M |
| Gain Therapeutics | 71.66M |
| Eloxx Pharmaceuticals | 70.35M |
| Rein Therapeutics | 68.61M |
| Alps Group | 68.27M |
| XBiotech | 67.99M |
| Spero Therapeutics | 67.74M |
| OS Therapies | 67.70M |